Hematological parameters in association with outcomes in sickle cell anemia patients

Indian Journal of Medical Sciences

Volumn 65, Issue 9, 2011, Pages 393-398

  Emmanuelchide, Okocha ^a   Charle, Odenigbo ^a   Uchenna, Okonkwo ^a  

^a NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

Author keywords

Individualized therapy; packed cell volume; sickle cell disease outcomes; white blood cell count

Indexed keywords

ADULT; ARTICLE; DISEASE ASSOCIATION; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OSTEOMYELITIS; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SEX RATIO; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD CELL COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEMATOCRIT; HUMANS; INFANT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84875475793     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.108955     Document Type: Article

References (17)

1. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997;337:762-9
2. Okpala I. The intriguing contribution of white blood cells to sickle cell disease: A red cell disorder. Blood Rev 2004;18:65-73
3. Sarris I, Litos M, Bewley S, Okpala I, Seed P, Oteng-Ntim E. Platelet count as a predictor of the severity of sickle cell disease during pregnancy. J Obstet Gynaecol 2008;28:688-91
4. Thomas PW, Higgs DR, Serjeant GR. Benign clinical course in homozygous sickle cell disease: A search for predictors. J Clin Epidemiol 1997;50:121-6
5. Anyaegbu CC, Okpala IE, Akren'Ova YA, and Salimonu LS. Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA). Eur J Haematol 1998;60:267-8
6. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44
7. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998;91:288-94
8. Powars DR. Management of cerebral vasculopathy in children with sickle cell anaemia. Br J Haematol 2000;108:666-78
9. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, et al. The acute chest syndrome in sickle cell disease: Incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994;84:643-9
10. Frenette PS. Sickle cell vaso-occlusion: Multistep and multicellular paradigm. Curr Opin Hematol 2002;9:101-6
11. Okpala I. Leukocyte adhesion and the pathophysiology of sickle cell disease. Curr Opin Hematol 2006;13:40-4
12. Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM. Activated monocytes in sickle cell disease: Potential role in the activation of vascular endothelium and vaso-occlusion. Blood 2000;96:2451-9
13. Charache S. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Semin Hematol 1997;34:15-21
14. Gutsaeva DR, Parkerson JB, Yerigenahally SD, Kurz JC, Schaub RG, Ikuta T, et al. Inhibition of cell adhesion by anti-P-selectin aptamer: A new potential therapeutic agent for sickle cell disease. Blood 2011;117:727-35
15. Howard RJ, Tuck SM, Pearson TC. Optimal haematocrit and haemoglobin S levels in pregnant women with sickle cell disease. Clin Lab Haematol 1995;17:157-61
16. Phillips G Jr, Coffey B, Tran-Son-Tay R, Kinney TR, Orringer EP, Hochmuth RM. Relationship of clinical severity to packed cell rheology in sickle cell anemia. Blood 1991;78:2735-9
17. Keidan AJ, Marwah SS, Vaughan GR, Franklin IM, Stuart J. Painful sickle cell crises precipitated by stopping prophylactic exchange transfusions. J Clin Pathol 1987;40:505-7